Mid Atlantic Chapter

T1D Clinical Trials in the Mid-Atlantic Region

Participate in a T1D Clinical Trial

Choosing to participate in a T1D clinical trial is a very personal decision, but one that can have a significant impact on curing, preventing and treating T1D. Explore additional clinical trial resources from JDRF and our partners at Beyond Type 1 to learn more about clinical trials and their phases.

There are many opportunities in Maryland, Virginia, and Washington, DC to participate in a T1D clinical trial close to home. See below for active opportunities. You can also utilize JDRF’s Clinical Trials Connection tool to find additional opportunities.

If you have any questions, please contact one of our Mid-Atlantic Chapter Clinical Trials Education Volunteers: Tom Brobson or Mike Anderson.



The PROTECT Study will assess how well an investigational medicine, called teplizumab, works in children and adolescents (age 8-17) recently diagnosed (six weeks or less) with T1D. Learn more and find a study clinic here. Local sites include Camp Springs, MD, Philadelphia, PA and Chapel Hill, NC. 


Afrezza INHALE-1 Study in Pediatrics (INHALE-1)
This study aims to evaluate the safety and effectiveness of a rapid-acting inhaled insulin product for use in children and teenagers with diabetes.  Qualified participants will either take inhaled insulin for 12 months or continue mealtime injectable insulin for 6 months and then switch to inhaled insulin for the final 6 months. Read more.

PARTICIPANT AGE: 4-17 with type 1 or type 2 diabetes and using mealtime insulin (vial or pen, no pumps)

LOCATION: 26 study locations including Baltimore, MD

CONTACT: Call 1-844-INHALE1 or visit https://go.afrezza.com/inhale1


A study to learn about sugar-free foods and beverages for type 1 diabetes management.

PARTICIPANT AGE: 5-14; must have had T1D for at least one year

LOCATION: Requires two in-person visits to Children’s National in Washington, DC and additional virtual meetings

CONTACT: Text/call (202) 618-2207 or drinkt1d@email.gwu.edu


Low Calorie Sweetener and Quality of Life Study
A study to learn about quality of life in youth with type 1 diabetes.

PARTICIPANT AGE: 11-17; must have had T1D for at least one year

LOCATION: Virtual (One 30-minute Zoom meeting and online surveys)

CONTACT: drinkt1d@email.gwu.edu


Artificial Pancreas – Adolescent Physiology & Psychology Longitudinal Evaluation (AP APPLE)
UVA Center for Diabetes Technology is recruiting boys and girls who are 11 or 12 years old, going through puberty, and have been diagnosed with T1D for a 2-year research study. The study assesses changes in insulin resistance, glucose response, and psychosocial factors that are related to adolescent T1D management and glycemic control during their pubertal stages. The study requires four in-person visits and 15 phone or email check-in visits and there is $800 compensation for completion of the entire study.


LOCATION: Charlottesville, VA and virtual

CONTACT: Lianna Smith at 434-284-0893 or lhs7px@uvahealth.org



COVID-19 Booster Vaccine Study in People with Type 1 Diabetes
Clinicians from Johns Hopkins are conducting a research study to see if the COVID-19 Booster Vaccine increases glucose levels or insulin requirements in patients with type 1 diabetes.


LOCATION:  Suburban Hospital and Howard County General Hospital Medical Campus


Rocket BPS Study
UVA Center for Diabetes Technology is seeking adults between the ages of 18-65 who have T1D to participate in a study that measures blood glucose levels when using a bolus priming system. Participants will be asked to complete 5 visits for this study. Most visits can be done by telephone but one visit will require a 96-hour hotel stay. There will be no cost for the hotel stay and meals will be provided. Participants will be asked to wear a Tandem insulin pump and Dexcom G6 sensor during their stay. Participants will be able to walk around the hotel or enjoy quiet activities in their hotel room and will be asked to participate in some exercise and food challenges.


LOCATION: Charlottesville, VA and virtual

CONTACT: Morgan Fuller at mf2nu@virginia.edu or (434) 242-9379 or Olivia McLean at ohm2eh@uvahealth.org or (434) 466-6744


Adapting Diabetes Treatment Expert Systems to Patient’s Expectations and Psychobehavioral Characteristics in Type 1 Diabetes
UVA Center for Diabetes Technology seeks adults ages 18 and up with T1D for a research study to test different ways CGM data can be used to help manage diabetes. This study involves using a Dexcom G6 sensors, and an investigational diabetes application on an Android smart phone. Participants currently using multiple daily injections (MDI) may use a study insulin pump, if desired. There will be weekly surveys to complete, as well as 3 separate blood draws for A1c and lab values. This study will last approximately 7 months and there will be approximately 7 visits. All of these visits can be completed virtually using a web-based video conferencing tool. Study-related Dexcom G6 sensors, transmitters, and infusion sets if applicable will be provided free of charge.


LOCATION: Virtual or in-person in Charlottesville, VA

CONTACT: Emma Emory, EE9M@virginia.edu or 434-982-6479


A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes
Read more about this clinical trial and its study site at VCU Medical Center in Richmond, VA here.


Are you interested in participating in a clinical trial but these aren’t right for you? Check out JDRF’s Clinical Trial Matching Tool, which can potentially match you with a clinical trial. You can also contact one of our Mid-Atlantic Chapter Clinical Trials Education Volunteers: Tom Brobson or Mike Anderson.

More from the Mid Atlantic Chapter

Chapter Homepage